Key result
Ultrasound-measured visceral adipose tissue (VAT) thickness showed a strong correlation with MRI (r = 0.82) and provided fair diagnostic accuracy for metabolic syndrome and prediabetes in women.
Why the study?
To evaluate the accuracy of ultrasound compared with gold-standard MRI for assessing abdominal fat distribution, and to determine its association with metabolic conditions in adults with abdominal obesity.
Does ultrasound accurately measure abdominal fat distribution compared to MRI and predict metabolic conditions in adults with abdominal obesity?
Cross-Sectional (n=113)
No
Does ultrasound accurately measure abdominal fat distribution compared to MRI and predict metabolic conditions in adults with abdominal obesity?
Effect estimate: r = 0.82
p-value: p=<0.001
Ultrasound represents a useful, non-invasive screening tool for visceral adipose tissue thickness evaluation that correlates well with MRI and is positively associated with prediabetes and metabolic syndrome, particularly in women.
May support ultrasound VAT screening in women with abdominal obesity; extends MRI correlation data but leaves open prospective validation.
AIMS: To evaluate the accuracy of abdominal fat distribution of subcutaneous (SAT) and visceral adipose tissue (VAT) assessed by ultrasound (US) compared to magnetic resonance imaging (MRI), as the gold standard technique. Additionally, to assess the association between abdominal fat distribution measured by US and metabolic conditions in adults with abdominal obesity. MATERIALS AND METHODS: A cross-sectional study (ClinicalTrials.gov: NCT05882149) included 113 individuals (65.5% women) with waist circumference ≥102 cm for men and ≥88 cm for women. VAT and SAT were measured by both US and MRI. Diagnostic performance was evaluated using ROC curve analysis. RESULTS: Participants were (mean ± SD) 52.8 ± 10.9 years old. VAT thickness measured by US showed a strong correlation with MRI (r = 0.82). For prediabetes, US-measured VAT thickness showed fair diagnostic accuracy in women (AUC = 0.71) with a proposed cut-off of 5.87 cm. For metabolic syndrome, US-measured VAT thickness showed poor diagnostic accuracy in women (AUC = 0.69), with a proposed cut-off of 4.83 cm. Also, VAT/SAT ratio (thickness) measured by US showed fair diagnostic accuracy for prediabetes in women (AUC = 0.72), with a proposed cut-off of 3.04, and poor diagnostic accuracy for metabolic syndrome in women (AUC = 0.69), with a proposed cut-off of 2.52. CONCLUSIONS: Ultrasound represents a useful screening tool for VAT thickness evaluation with an easy translation to clinical practice. Particularly, VAT thickness and VAT/SAT ratio (thickness) are positively associated with prediabetes and metabolic syndrome, especially in women.
No takes yet. Share an insight, caveat, or question.
Hoevel et al. (2025) conducted a cross-sectional in Abdominal obesity (n=113). Ultrasound-measured visceral adipose tissue (VAT) thickness vs. Magnetic resonance imaging (MRI) was evaluated on Correlation between VAT thickness measured by ultrasound and MRI (r = 0.82, p=<0.001). Ultrasound-measured visceral adipose tissue (VAT) thickness showed a strong correlation with MRI (r = 0.82) and provided fair diagnostic accuracy for metabolic syndrome and prediabetes in women.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: